Skip to main content

DELAFIELD, Wis. (Stockpickr) -- Corporate insiders sell their own companies' stock for a number of reasons. 

They might need the cash for a big personal purchase such as a new house or yacht, or they might need the cash to fund a charity. Sometimes they sell as part of a planned selling program that they have put in place for diversification purposes, which allows them to sell stock in stages instead of selling all at one price.

Other times they sell because they think their stock is overvalued and the risk/reward is no longer attractive. Some even dump their own stock because they have inside knowledge that a competitor is eating their lunch and stealing market share. 

But insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.

The key word in that last statement is "think." Just because a corporate insider thinks his or her stock is going to trade higher, that doesn't mean it will play out that way. Insiders can have all the conviction in the world that their stock is a buy, but if the market doesn't agree with them, the stock could end up going nowhere. Also, I say "usually" because sometimes insiders are loaned money by the company to buy their own stock. Those loans are often sweetheart deals and shouldn't be viewed as organic insider buying.

At the end of the day, it's institutional money managers running big mutual funds and hedge funds that drive stock prices, not insiders. That said, many of these savvy stock operators will follow insider buying activity when they agree with the insider that the stock is undervalued and has upside potential. This is why it's so important to always be monitoring insider activity but twice as important to make sure the trend of the stock coincides with the insider buying.

Recently, a number of companies' corporate insiders have bought large amounts of stock. These insiders are finding some value in the market, which warrants a closer look at these stocks.

Pioneer Natural Resources

One energy player that insiders are loading up on here is Pioneer Natural Resources (PXD) - Get Pioneer Natural Resources Company Report , which engages in the exploration and production of oil and gas in the U.S. Insiders are buying this stock into big weakness, since shares have dropped by 27.6% over the last six months.

Pioneer Natural Resources has a market cap of $17.6 billion and an enterprise value of $20 billion. This stock trades at a fair valuation, with a trailing price-to-earnings of 34.8 and a forward price-to-earnings of 211.5. Its estimated growth rate for this year is -98.5%, and for next year it's pegged at 700%. This is not a cash-rich company, since the total cash position on its balance sheet is $219 million and its total debt is $2.67 billion.

The CFO just bought 117,786 shares, or about $14.11 million worth of stock, at $119.85 per share.

From a technical perspective, Pioneer Natural Resources is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been uptrending over the last month and change, with shares moving higher from its low of $105.80 to its recent high of $127.07 a share. During that uptrend, shares of Pioneer Natural Resources have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed this stock within range of triggering a near-term breakout trade above some key overhead resistance levels.

If you're bullish on Pioneer Natural Resources, then I would look for long-biased trades as long as this stock is trending above some near-term support levels at $116.97 to $114.79 and then once it breaks out above some near-term overhead resistance levels at its 20-day moving average of $120.45 to its 50-day moving average of $122.19 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 2.16 million shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $127.07 to $130.78, or even $133 to $135 a share.

Staar Surgical

Another healthcare player that insider are active in here is Staar Surgical (STAA) - Get STAAR Surgical Company Report , which designs, develops, manufactures and sells implantable lenses for the eye, and delivery systems to deliver lenses into the eye. Insiders are buying this stock into notable weakness, since shares have fallen by 26.5% over the last three months.

TheStreet Recommends

Staar Surgical has a market cap of $285 million and an enterprise value of $273 million. This stock trades at a premium valuation, with a forward price-to-earnings of 717. Its estimated growth rate for this year is 27.3%, and for next year it's pegged at 106.2%. This is a cash-rich company, since the total cash position on its balance sheet is $15.34 million and its total debt is $4.71 million.

A beneficial owner just bought 311,099 shares, or about $2.2 million worth of stock, at $7.07 to $7.13 per share.

From a technical perspective, Staar Surgical is currently trending below both its 50-day and 20-day moving averages, which is bearish. This stock has recently been attempting to carve out a double bottom chart pattern, since shares have found some buying interest at $6.84 to $6.74 a share. Shares of Staar Surgical have now started to spike higher off those double bottom support levels and it's beginning to move within range of triggering a near-term breakout trade.

If you're in the bull camp on Staar Surgical, then I would look for long-biased trades as long as this stock is trending above those double bottom support levels and then once it breaks out above some near-term overhead resistance levels at its 20-day moving average of $7.73 and above its 50-day moving average of $7.92 a share with volume that hits near or above its three-month average action of 137,289 shares. If that breakout hits soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $8.33 to $8.60, or even $8.81 to $9.15 a share.

Cheniere Energy

One energy player that insiders are snapping up a ton of stock in here is Cheniere Energy  (LNG) - Get Cheniere Energy, Inc. Report , which engages in the liquefied natural gas related business. Insiders are buying this stock into large weakness, since shares plunged by 36.7% over the last six months.

Cheniere Energy has a market cap of $11.8 billion and an enterprise value of $24.3 billion. This stock trades at a premium valuation, with a price-to-sales of 40.54. Its estimated growth rate for this year is 14.3%, and for next year it's pegged at 68.4%. This is not a cash-rich company, since the total cash position on its balance sheet is $1.47 billion and its total debt is $14.88 billion.

A beneficial owner just bought 2,042,928 shares, or about $96.30 million worth of stock, at $47.14 per share.

From a technical perspective, Cheniere Energy is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been downtrending badly over the last six months, with shares falling sharply off its high of $78.25 to its recent low of $46.23 a share. During that downtrend, shares of Cheniere Energy have been consistently making lower highs and lower lows, which is bearish technical price action. That said, this stock has now started to bounce off that $46.23 low and it's beginning to move within range of triggering a near-term breakout trade.

If you're bullish on Cheniere Energy, then I would look for long-biased trades as long as this stock is trending above its recent low of $46.23 and then once it breaks out above some near-term overhead resistance levels at $50 to $50.50 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average volume of 4.10 million shares. If that breakout materializes soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 20-day moving average of $52.80 to $56.40, or even its 50-day moving average of $60.23 a share.

Calithera Biosciences

One clinical-stage biopharmaceutical player that insiders are in love with here is Calithera Biosciences (CALA) - Get Calithera Biosciences, Inc. Report , which focuses on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the U.S. Insiders are buying this stock into massive weakness, since shares have plunged by 68.3% over the last six months.

Calithera Biosciences has a market cap of $93 million and an enterprise value of $12.8 million. This stock trades at a reasonable valuation, with a price-to-book of 1.04. Its estimated growth for this year is 58.5%, and for next year it's pegged at -51%. This is a cash-rich company, since the total cash position on its balance sheet is $77.7 million and its total debt is zero.

A beneficial owner just bought 106,968 shares, or about $644,000 worth of stock, at $6 to $6.07 per share.

From a technical perspective, Calithera Biosciences is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has just started to spike higher right off some near-term support at $4.91 a share. That spike is starting to push shares of Calithera Biosciences within range of triggering a big breakout trade above some key near-term overhead resistance levels.

If you're bullish on Calithera Biosciences, then I would look for long-biased trades as long as this stock is trending above some key near-term support levels at $4.91 or at $4.31 and then once it breaks out above some near-term overhead resistance levels at $5.66 to $6.29 a share and then above more resistance at $6.78 to $6.82 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 612,211 shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $8 to $9 a share, or even $10.50 a share.

Sears Holdings

One final stock with some big insider buying is department store player Sears Holdings (SHLD) , which operates as a retailer in the U.S. Insiders are buying this stock into massive weakness, since shares have dropped by 43% over the last six months.

Sears Holdings has a market cap of $2.5 billion and an enterprise value of $4 billion. This stock trades at a cheap valuation, with a price-to-sales of 0.09. Its estimated growth for this year is -24%, and for next year it's pegged at 6.9%. This is not a cash-rich company, since the total cash position on its balance sheet is $1.82 billion and its total debt is $3.31 billion.

The CEO just bought 233,655 shares, or about $5.81 million worth of stock, at $24.84 to $24.96 per share. From a technical perspective, Sears Holdings is currently trending above its 50-day moving average and below its 200-day moving average, which is neutral trendwise. This stock has just started to trend back above its 50-day moving average of $24.27 a share. That trend is starting to push shares of Sears Holdings within range of triggering a major breakout trade above some key near-term overhead resistance levels.

If you're bullish on Sears Holdings, then I would look for long-biased trades as long as this stock is trending above some key near-term support at $23.21 a share and then once it breaks out above its 20-day moving average of $25.50 and then above more key resistance levels at $27 to $28.31 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 999,134 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $30 to its 200-day moving average of $32.91 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.